{"prompt": "['NET-PRO Protocol v1.3', 'April 2022', 'Milestone', 'Milestone - Deliverable Name', 'Description', 'Due Date', 'Completion', 'Projected', 'Deliverable', 'date', 'Completion', 'ID', 'Date', 'B13', 'Program and configure patient', 'UICC staff will program consent functionality and', 'health record (PHR) portal for', 'baseline surveys in the PHR portal', '4/13/2022', '9/30/2021', 'consent and baseline surveys', 'B14', 'Execute Data Use Agreements', 'DUAs with institutions owning data are complete.', '(DUAs)', '5/31/2022', '11/15/2021', 'B15', 'Provide permission to share', 'Submit memo confirming permission to share', 'reporting documents with the', 'approved project, recruitment, and engagement', 'PCORnet Coordinating Center', 'plans, status reports, recruitment, enrollment and', '(CC) to support a learning', 'retainment numbers (where applicable), and', 'network.', 'evaluation materials with the PCORnet CC for', '12/29/2021', 'streamlined coordination and to contribute to the', '1/1/2022', 'PCORnet dashboard. All study teams will be expected', 'to present to the Steering Committees (SC). Ample', 'notice and specific topics will be given in preparation', 'for any presentation requests.', 'B16', 'Submit updated Data Safety', 'Refer to the PCORI Policy on Data Safety and', 'and Monitoring Plan to PCORI.', 'Monitoring Plans for PCORI-Funded Research.', '12/21/2021', '1/1/2022', 'B17', 'Submit updated Engagement', 'Elements of the updated Engagement Plan should', 'Plan in PCORI Online.', 'include:', 'a. Update roster of committee/panel members with', 'short bios', 'b. A Patient and/or Stakeholder Advisory Panel(s) or', 'Committee(s) Governance Schematic', 'c. Planned training for patients and other stakeholder', '12/30/2021', 'partners on the research process', '1/1/2022', 'd. Proposed Meeting Schedule', 'e. Tasks or opportunities wherein patients and/or', 'stakeholders will have input via consultation,', 'collaboration or leadership', 'f. Efforts to Evaluate/Assess Engagement', 'B18', 'Validation of computable', 'Submit evidence of validation of computable', 'phenotype for cohort', 'phenotype for rare disease cohort; evaluate fit for', '12/21/2021', 'identification', 'intended use.', '1/1/2022', 'B19', 'Cohort identification', 'Participating CRNs will have identified the rare disease', 'cohort for study. Submit evidence of cohort', '5/18/2022', 'identification. Submit a report on study groups,', '1/1/2022', 'demographics and other characteristics to PCORI', 'B20', 'Complete query to identify', 'Using queries developed by the study and', 'cohort across non-participating', 'coordinating center programmers, test feasibility of', 'CRNs', 'identifying the cohort through the Front Door in non-', 'participating CRNs. Submit report to PCORI via PCORI', '12/18/2021', 'Online system summarizing number and names of', '1/1/2022', 'responding network partners, cohort size, and other', 'relevant patient characteristics.', 'B21', 'Data linkage assessment', 'Evaluate whether the quality and quantity of data in', 'Need to', 'the datasets proposed for data linkage is sufficient to', '3/11/2022', '1/1/2022', 'resubmit', 'meet primary research aims.', 'B22', 'Data linkage plan', 'Develop a data linkage plan that corresponds with', 'PCORnet Common Data Linkage, if available, in', '12/31/2021', '1/1/2022', 'collaboration with the dataset owner(s).', 'B23', '100% of the IRB approvals', 'Update IRB information in PCORI Online', 'across sites submitted to PCORI', '5/31/2022', '1/1/2022', 'B', 'Report Submission', 'Submit Interim Progress Report to PCORI via the', 'PCORI Online system accessed through:', '12/29/2021', '1/1/2022', 'https://pcori.force.com/engagement', 'C1', 'Finalize comparators for Aims 2', 'The collection of HRQoL information from Aim 1 will', '& 3', 'be available for a decent sample of NET patients at', 'this time. Information from Aim 1 will be used - with', '5/31/2022', 'input from the Patient Advocacy Committee (PAC) and', '2/28/2022', 'Clinician Group - to finalize the comparators for Aims', '2 and 3.', '45']['NET-PRO Protocol v1.3', 'April 2022', 'Milestone', 'Milestone - Deliverable Name', 'Description', 'Due Date', 'Completion', 'Projected', 'Deliverable', 'date', 'Completion', 'ID', 'Date', 'C2', 'Patient enrollment (25%)', '25% of participants (N = 753) screened, enrolled, and', 'consented to the study.', '6/30/2022', '3/1/2022', 'C3', 'Validate Study Preliminary', 'Complete validation of sample of events. (Number and', 'Results', 'type of events will be distributed across the', 'participating CRNs to assure appropriate', 'representation.) Provide a summary of preliminary', '5/1/2022', 'results of the validation study in interim progress', 'report.', 'C4', 'Presentation to PCORnet', 'Annual presentation to PCORnet Steering Committee', 'Steering Committee', 'on progress of study, lessons learned, and', 'recommendations for improvement of PCORnet', '7/1/2022', 'infrastructure', 'C', 'Report Submission', 'Submit Interim Progress Report to PCORI via the', 'PCORI Online system accessed through:', '7/1/2022', 'https://pcori.force.com/engagement', 'D1', 'Finalize and submit copy of', 'Refer to the PCORI Methodology Standards for', 'revised study protocol in PCORI', 'required elements of the study protocol.', '7/1/2022', 'Online.', 'D2', 'NET PHR portal finalized', 'Design parameters and feedback from NET patient', 'sessions is incorporated into the NET PHR, tested, and', 'ready for deployment for existing and future enrollees', '7/1/2022', 'D3', 'Submit IRB Continuing approval', 'Submit IRB approval of revised study protocol via the', 'PCORI Online system.', '7/1/2022', 'D4', 'Programmatic evaluation', 'Submit document that demonstrates study progress', 'materials due to PCORI.', 'and feasibility based on metrics provided by PCORI to', 'awardee. PCORI initiates Programmatic Evaluation.', 'Metrics will include: the validity of cohort', 'identification and its size and characteristic; feasibility', 'of recruitment; generalizability of the sample;', 'feasibility of data linkages (if relevant); validity and', '7/1/2022', 'completeness of study outcomes; suggestions of', 'needed enhancements or revisions to study protocol,', 'as well as associated timeline. PCORI will provide', 'recommendations about proceeding to next steps of', 'the study within 45 days.', 'D5', 'Patient enrollment (50%)', '50% of participants (N = 1505) screened, enrolled, and', 'consented to the study.', '10/1/2022', 'D', 'Report Submission', 'Submit Interim Progress Report to PCORI via the', 'PCORI Online system accessed through:', '1/1/2023', 'https://pcori.force.com/engagement', 'E1', 'Patient enrollment (75%)', '75% of participants (N N=2258) screened, enrolled, and', 'consented to the study.', '6/1/2023', 'E2', 'Submit IRB Continuing approval', 'Submit IRB approval of revised study protocol via the', 'PCORI Online system.', '7/1/2023', 'E3', 'Presentation to PCORnet', 'Annual presentation to PCORnet Steering Committee', 'Steering Committee', 'on progress of study, lessons learned, and', 'recommendations for improvement of PCORnet', '7/1/2023', 'infrastructure', 'E', 'Report Submission', 'Submit Interim Progress Report to PCORI via the', 'PCORI Online system accessed through:', '7/1/2023', 'https://pcori.force.com/engagement', 'F1', 'Develop dissemination plan for', 'Submit dissemination plan to PCORI via PCORI Online', 'rare disease tools and', 'system', '1/1/2024', 'resources', 'F', 'Report Submission', 'Submit Interim Progress Report to PCORI via the', 'PCORI Online system accessed through:', '1/1/2024', 'https://pcori.force.com/engagement', 'G1', 'Patient enrollment (100%)', '100% of participants (N = 3010) screened, enrolled,', 'and consented to the study.', '2/1/2024', '46']\n\n###\n\n", "completion": "END"}